Tamoxifen free base, tamoxifen free base and 1 more item

The University of Virginia awarded contract A207_PO-0119166-V3 to Sigma-Aldrich Inc on August 8, 2026, with a total cumulative contract value of $267. The contract encompasses the procurement of two primary chemical/pharmaceutical products: Tamoxifen Free Base and Anti-LHFPL5 (anti-lipoma HEFTI-like protein 5 antibodies). The Tamoxifen Free Base line item specifies a quantity of 267 units at a unit price of $1 each, while the Anti-LHFPL5 line item is priced at $1 per unit with quantity details not fully specified in the available documentation. Both items are designated for delivery to the contracting organization's buyer.

As a Virginia-based institutional procurement, this contract award reflects a routine chemical supply transaction between a major research university and an established life sciences supplier. Sigma-Aldrich Inc, a recognized vendor in the chemical and pharmaceutical supply sector, fulfilled the University of Virginia's requirement for research-grade materials. The contract documentation does not specify an explicit period of performance, annual value, or detailed performance location beyond the contracting organization itself. The minimal contract value of $267 suggests this represents either a small incremental procurement or a unit-priced supply agreement for limited quantities of specialized research materials.